High titers of NAbs and moderate cellular immunity increase the chance of treatment and reduce the risk of ADE, while antigens that induce large amounts of Th2 cytokines (such as IL-5 and IL-13) are prone to cause ADE [138,139]. This evidence concerns the gene IL5 and acute disseminated encephalomyelitis.